当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析

惠泰医疗

(688617)

  

流通市值:290.13亿  总市值:290.13亿
流通股本:1.42亿   总股本:1.42亿

惠泰医疗(688617)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.26亿元,每股收益1.64元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益300710.38万元,未分配利润252164.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产343050.50万元,负债42340.12万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入704,078,336.742,583,927,321.091,867,437,461.291,213,804,906.53
营业总成本451,345,627.261,672,065,165.221,191,415,119.57752,300,167.35
其他经营收益
营业利润265,642,094.3944,558,555.84710,662,982.14483,304,979.16
利润总额265,527,279.38936,290,399.51705,751,543.8479,340,286.62
净利润225,762,046.92807,739,206.52614,819,029.79418,900,671.88
每股收益
其他综合收益-454,815.08406,783.214,244,439.092,191,973.46
综合收益总额225,307,231.84808,145,989.73619,063,468.88421,092,645.34
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,882,479,270.462,122,233,847.441,978,815,743.521,781,575,753.24
非流动资产:
非流动资产合计1,548,025,759.681,529,622,799.641,481,937,296.441,440,924,761.17
资产总计3,430,505,030.143,651,856,647.083,460,753,039.963,222,500,514.41
流动负债:
流动负债合计361,857,732.81458,960,421.29367,679,331.39348,102,859.99
非流动负债:
非流动负债合计61,543,477.2362,546,856.6355,823,394.6645,117,968.07
负债合计423,401,210.04521,507,277.92423,502,726.05393,220,828.06
所有者权益(或股东权益):
归属于母公司股东权益合计2,969,091,600.663,088,667,057.762,988,822,083.242,794,367,389.65
股东权益合计3,007,103,820.13,130,349,369.163,037,250,313.912,829,279,686.35
负债和股东权益合计3,430,505,030.143,651,856,647.083,460,753,039.963,222,500,514.41
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计840,665,509.312,974,884,678.512,143,203,311.231,398,374,210.86
经营活动现金流出小计648,468,567.792,007,125,019.731,467,144,111.77953,725,557.93
经营活动产生的现金流量净额192,196,941.52967,759,658.78676,059,199.46444,648,652.93
投资活动产生的现金流量:
投资活动现金流入小计508,321,312.372,523,194,329.391,735,713,312.31,212,932,925.25
投资活动现金流出小计612,498,258.323,042,376,718.212,329,491,613.41,478,864,010.4
投资活动产生的现金流量净额-104,176,945.95-519,182,388.82-593,778,301.1-265,931,085.15
筹资活动产生的现金流量:
筹资活动现金流入小计5,985,437.354,936,123.8143,776,853.7827,373,979.28
筹资活动现金流出小计356,659,693.2334,680,002.8231,415,118.32224,066,169.41
筹资活动产生的现金流量净额-350,674,255.9-279,743,878.99-187,638,264.54-196,692,190.13
汇率变动对现金及现金等价物的影响-6,876,599.69-3,790,697.36-876,175.642,149,549.56
现金及现金等价物净增加额-269,530,860.02165,042,693.61-106,233,541.82-15,825,072.79
期末现金及现金等价物余额976,599,744.621,246,130,604.64974,854,369.211,065,262,838.24
补充资料:
现金及现金等价物的净增加额-165,042,693.61--15,825,072.79
最新报告期:2026-05-11
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
招商证券梁广楷,许菲菲,郭子娴7.189.0011.172026-05-11
野村东方国际证券孔令岩,朱小溪7.469.4811.642026-05-08
中信证券宋硕,陈竹,曾令鹏7.208.9711.182026-04-29
中金公司俞波,张琎7.148.75--2026-04-28
中信建投郑涛,朱琪璋,王在存,贺菊颖7.158.9211.122026-04-27
TOP↑